« Back to Record
Untch, M., Gelber, R. D., Jackisch, C., Procter, M., Baselga, J., Bell, R. H., Cameron, D. A., Bari, M., Smith, I., Leyland-Jones, B., de Azambuja, E., Wermuth, P., Khasanov, R., Feng-Yi, F., Constantin, C., Mayordomo, J. I., Su, C.-H., Yu, S.-Y., Lluch, A., Senkus-Konefka, E., Price, C., Haslbauer, F., Suarez Sahui, T., Srimuninnimit, V., Colleoni, M. A., Coates, A., Piccart-Gebhart, M., Goldhirsch, A., & HERA study team, (2008). Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Annals of oncology, 19(6), 1090-1096. doi:10.1093/annonc/mdn005
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55858



